Discovery-driven research leads to breakthrough in understanding rare Sengers syndrome

July 14, 2017 by Kathryn Powley
Credit: University of Melbourne

Melbourne researchers have unlocked important information that could lead to improved treatment of a rare and serious genetic condition.

Sengers syndrome is a genetic mitochondrial disease. Most children born with it die as babies, but a milder form of the disease also exists with some people surviving for multiple decades.

The new research, which involved a collaboration between the University of Melbourne's Bio21 Institute, the Murdoch Childrens Research Institute, Monash University and La Trobe University, uncovered an unexpected link between the gene that causes Sengers syndrome, AGK, and a cellular process referred to as " transport".

Professor David Thorburn's team identified changes in the AGK gene as the cause of Sengers syndrome in 2012. However, it was unclear how the expected of AGK led to the abnormal mitochondrial function they found in the two Australian patients identified at that time. Subsequently another 30 patients have been described internationally, most of whom suffer from severe heart disease and cataracts.

Dr Diana Stojanovski investigated the inner workings of AGK and what she found could lead to improved treatments and therapies for the incurable condition.

Dr Stojanovski explains that the mitochondrion is an organelle found in all cells of our bodies and considered the "powerhouse" of the cell, where the food we eat is metabolised into energy to sustain life and organ function. When mitochondria don't function properly organs fail and people get sick.

Mitochondria is bound by a double membrane with "gate-keepers" or "carrier proteins" embedded in the inner membrane that regulate which molecules and metabolites can enter.

The molecules that pass through these gate-keepers are needed for various important processes, such as the metabolism of fats and proteins for energy.

"Inside the mitochondria you have a number of tiny molecular machines that are responsible for assembling these gate-keeper molecules so they can do their job," Dr Stojanovski says.

"This is a highly tuned process. When these machines have faulty parts, then it can have severe effects on our metabolism, like what we see in Sengers sydnrome."

Dr Stojanovski's team found the AGK belonged to a molecular machine known as TIM22, which organises tunnel-like carrier proteins into the inner membrane, which then transport molecules into and out of the organelle.

This function was crucial for various processes, including energy production.

"Until this discovery Sengers syndrome was believed to be a defect of lipid metabolism in cells," Dr Stojanovski says. "Our work is paradigm-shifting and suggests defects in the process of leads to the disease."

Explore further: Researchers sniff out potential Leigh syndrome treatment

Related Stories

Researchers sniff out potential Leigh syndrome treatment

July 18, 2016
A mouse with dysfunctional mitochondria may hold the key to treating Leigh syndrome in humans.

Unravelling the genetic mystery behind mitochondrial disease

September 15, 2016
Researchers from the Monash Biomedicine Discovery Institute in Melbourne have identified two new genes linked to a major cause of mitochondrial disease. Their research opens the way for better genetic diagnosis of the disease ...

Unraveling the mystery of DNA attacks in cells' powerhouse could pave way for new cancer treatments

April 28, 2017
New research has unravelled the mystery of how mitochondria—the energy generators within cells—can withstand attacks on their DNA from rogue molecules.

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.